L. acidophilus prevents cholesterol gallstones in mice by regulating gut microbiota-mediated BAs metabolism and cholesterol homeostasis Mengyan Du, Lvwang Ye, Cong Wang, Ting Jiang, Fang Liu Journal of Functional Foods.2026; 139: 107194. CrossRef
GOLM1 and bile acid synthesis: Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers” Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen Clinical and Molecular Hepatology.2025; 31(2): e189. CrossRef
Reply to correspondence 2 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers” Nahee Hwang, Sungsoon Fang Clinical and Molecular Hepatology.2025; 31(2): e228. CrossRef
Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post‐Radiofrequency Ablation Yuezhan Shan, Hongyu Chu, Sheyu Ye, Guofeng Ji, Jiayi Zhao, Xinghui Si, Yumin Zhong, Youmao Tao, Jingwei Shi, Xuedong Fang Advanced Science.2025;[Epub] CrossRef
A demethylation chloroisosulochrin and a chromone metabolite from the endophytic fungus
Penicilium
sp.
Ke-Liang Chen, Xue Wang, Yang Liu, Yun-Bao Liu Journal of Asian Natural Products Research.2025; : 1. CrossRef
Sung Hoon Kim, M.D., Young-Hwa Chung, M.D.1, Soo Hyun Yang, M.D., Jeong A Kim, M.S.1,
Myoung Kuk Jang, M.D.2, Sung Eun Kim, M.D.1, Danbi Lee, M.D.1, Sae Hwan Lee, M.D.1,
Don Lee, M.D.1, Kang Mo Kim, M.D.1, Young Suk Lim, M.D.1, Han Chu Lee, M.D.1,
Yung Sang Lee, M.D.1, Dong Jin Suh, M.D.1
Korean J Hepatol 2009;15(3):320-330. Published online September 30, 2009
Background/Aims Osteopontin (OPN) is overexpressed in hepatocellular carcinoma (HCC) with postoperative recurrence or extrahepatic metastasis. However, its prognostic value in patients treated with transarterial chemoembolization (TACE) is unclear. We investigated the utility of serum OPN levels and changes therein as prognostic markers in HCC patients who have received TACE. Methods: Forty-six patients with HCC were enrolled. Serum OPN levels were measured before and 4 weeks after TACE. Serum biochemistry and computed tomography (CT) scans were analyzed. We evaluated baseline serum OPN levels and subsequent changes therein in relation to tumor responses and cumulative survival rates following TACE. A decreasing pattern was defined as a decrease after TACE of more than 10% relative to baseline levels. A "responder" was defined as a patient who exhibited a tumor necrosis rate of higher than 50% on the follow-up CT scan. Results: Higher initial serum OPN levels were associated with a large tumor, portal vein invasion, and an advanced tumor stage. Patients who had lower initial serum OPN levels and those who exhibited decreasing patterns after TACE tended to have more favorable tumor responses (P=0.043 and 0.055, respectively) and exhibited better cumulative survival rates (P=0.036 and 0.030, respectively). However, the initial serum OPN level and subsequent changes in serum OPN levels were not independent predictors for survival on multivariate analysis. Conclusions: Serum OPN levels were significantly higher in patients with advanced HCC. In addition, HCC patients with low pretreatment serum OPN levels and those for whom serum OPN declined following TACE exhibited better tumor responses and survived for longer. (Korean J Hepatol 2009,15:320-330)
Citations
Citations to this article as recorded by
A radiomics signature associated with underlying gene expression pattern for the prediction of prognosis and treatment response in hepatocellular carcinoma Dandan Wang, Linhan Zhang, Zhongqi Sun, Huijie Jiang, Jinfeng Zhang European Journal of Radiology.2023; 167: 111086. CrossRef
Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy Yuan-Mao Lin, Ryosuke Taiji, Marco Calandri, Bruno C. Odisio Current Oncology Reports.2021;[Epub] CrossRef
Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis Meng-Meng Liu, Zhan-Hong Chen, Li-Yun Zhao, Jing-Yuan Zhao, Dai-Lin Rong, Xiao-Kun Ma, Dan-Yun Ruan, Jin-Xiang Lin, Jing-Jing Qi, Pei-Shan Hu, Jing-Yun Wen, Jie Chen, Qu Lin, Xiang-Yuan Wu, Li Wei, Min Dong Oncology Research and Treatment.2021; 44(9): 450. CrossRef
ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications Danbi Lee, Myoung-Kuk Jang, Ji Hae Seo, Soo Hyung Ryu, Jeong A. Kim, Young-Hwa Chung Experimental & Molecular Medicine.2018; 50(7): 1. CrossRef
Prognostic value of osteopontin in patients with hepatocellular carcinoma Tingting Sun, Peng Li, Diwen Sun, Qingao Bu, Guoqiang Li Medicine.2018; 97(43): e12954. CrossRef
Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma James Ronald, Andrew B. Nixon, Daniele Marin, Rajan T. Gupta, Gemini Janas, Willa Chen, Paul V. Suhocki, Waleska Pabon-Ramos, David R. Sopko, Mark D. Starr, John C. Brady, Herbert I. Hurwitz, Charles Y. Kim Radiology.2017; 285(1): 311. CrossRef
Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC KUN DING, LU FAN, SHIJUN CHEN, YANNA WANG, HAIFENG YU, YANNI SUN, JIGUANG YU, LI WANG, XIANGZHONG LIU, YOUDE LIU Oncology Reports.2015; 34(6): 3297. CrossRef
Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway Yang You, Qiongdan Zheng, Yinying Dong, Yaohui Wang, Lan Zhang, Tongchun Xue, Xiaoying Xie, Chao Hu, Zhiming Wang, Rongxin Chen, Yanhong Wang, Jiefeng Cui, Zhenggang Ren, David Wai Chan PLOS ONE.2015; 10(8): e0134243. CrossRef
Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights Maria Tampaki World Journal of Hepatology.2015; 7(14): 1834. CrossRef
Meta-Analysis of the Prognostic and Diagnostic Significance of Serum/Plasma Osteopontin in Hepatocellular Carcinoma JiWen Cheng, WanLi Wang, CaiHong Sun, MuXing Li, Bo Wang, Yi Lv Journal of Clinical Gastroenterology.2014; 48(9): 806. CrossRef
Circulating markers for prognosis of hepatocellular carcinoma Kwong-Fai Wong, Zhi Xu, Jinfei Chen, Nikki P Lee, John M Luk Expert Opinion on Medical Diagnostics.2013; 7(4): 319. CrossRef
Plasma Osteopontin Level as a Diagnostic Marker of Hepatocellular Carcinoma in Patients with Radiological Evidence of Focal Hepatic Lesions Ashraf Khalil, Jamalat Elgedawy, Mohammed F Faramawi, Ashraf Elfert, Ibrahim Salama, Ahmed Abbass, Hala Elsaid, Hatem Elsebaai Tumori Journal.2013; 99(1): 100. CrossRef
Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and Osteopontin Ming-Chin Yu, Yun-Shien Lee, Sey-En Lin, Hsiang-Yao Wu, Tse-Ching Chen, Wei-Chen Lee, Miin-Fu Chen, Chi-Neu Tsai Annals of Surgical Oncology.2012; 19(S3): 455. CrossRef
Prognostic significance of osteopontin in hepatocellular carcinoma: A meta‐analysis Chuan‐Hai Zhang, Ge‐Liang Xu, Wei‐Dong Jia, Yong‐Sheng Ge, Jian‐Sheng Li, Jin‐Liang Ma, Wei‐Hua Ren International Journal of Cancer.2012; 130(11): 2685. CrossRef
ATX–LPA Axis Induces Expression of OPN in Hepatic Cancer Cell SMMC7721 Rihua Zhang, Zhihong Zhang, Xiaolin Pan, Xiayue Huang, Zuhu Huang, Guoxin Zhang The Anatomical Record.2011; 294(3): 406. CrossRef
Osteopontin as a Key Mediator for Vasculogenic Mimicry in Hepatocellular Carcinoma Wenbin Liu, Geliang Xu, Jinliang Ma, Weidong Jia, Jiansheng Li, Ke Chen, Wei Wang, Chen Hao, Yongcang Wang, Xiujun Wang The Tohoku Journal of Experimental Medicine.2011; 224(1): 29. CrossRef
Clinical Significance of Plasma Osteopontin Level in Egyptian Patients with Hepatitis C Virus-related Hepatocellular Carcinoma Sahar Saad El-Din Bessa, Nadia Mohamed Elwan, Ghada Abdul Moemen Suliman, Safinaz Hamdy El-Shourbagy Archives of Medical Research.2010; 41(7): 541. CrossRef
First
Prev
